Forward Citations = 0

Loading Chart...

5 inventors (with patents filed for the assignee):

Daniel J Abrams (4 out of 8 patents)

Michael Canney (1 out of 9 patents)

Thomas Joseph Anchordoguy (1 out of 1 patent)

4. Thomas J Anchordoquy (1 out of 3 patents)

5. Lisa Lynn Shafer (1 out of 15 patents)

4 patents: Sort by Forward Citations

1. 12029870 - Medical device having non-filtered CSF withdrawal pathway (2024-07-09),

2. 11511035 - Implantable intraventricular sampling and infusion access device (2022-11-29),

3. 11433038 - High concentration medicant solutions for treating neurological disorders (2022-09-06),

4. 10772857 - High concentration medicant solutions for treating neurological disorders (2020-09-15),

Company Overview

Cerebral Therapeutics, Inc. is a biopharmaceutical company focused on developing innovative therapies for patients with neurological disorders. Our mission is to advance treatments for conditions such as epilepsy, Parkinson's disease, and traumatic brain injury through cutting-edge research and development. By leveraging our expertise in neuroscience and drug delivery technology, we aim to improve the lives of those affected by these debilitating disorders.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 13 2026

4 Patents

#19 in Aurora, CO

#1,420 in Colorado

#60,641 in US

Aurora, CO, United States of America

Cerebral Therapeutics, Inc.

Forward Citations = 0

5 inventors:

Daniel J Abrams (4 out of 8 patents)

Michael Canney (1 out of 9 patents)

Thomas Joseph Anchordoguy (1 out of 1 patent)

4. Thomas J Anchordoquy (1 out of 3 patents)

5. Lisa Lynn Shafer (1 out of 15 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Cerebral Therapeutics, Inc.. Retrieved from https://idiyas.com/company/cerebral-therapeutics

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]